MPM
EW icon

MBB Public Markets’s Edwards Lifesciences EW Stock Holding History

MBB Public Markets’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,529
Closed -$276K – 194
2025
Q2 		$276K Sell
3,529
-793
-18% -$59.1K 0.03% 198
2025
Q1 		$313K Buy
+4,322
New +$309K 0.03% 304
2024
Q4 		– Sell
-3,330
Closed -$220K – 250
2024
Q3 		$220K Sell
3,330
-40,565
-92% -$2.95M 0.01% 546
2024
Q2 		$4.05M Buy
+43,895
New +$3.89M 0.08% 201
2022
Q1 		– Sell
-4,634
Closed -$600K – 212
2021
Q4 		$600K Buy
+4,634
New +$541K 0.01% 204

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

MBB Public Markets's EW Position: Q3 2025 in Review

MBB Public Markets sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 3,529 shares — an estimated $276K sold.

MBB Public Markets first reported a position in EW in Q4 2021 and held it in 5 quarters. The position peaked at $4.05M in Q2 2024. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • MBB Public Markets reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 3,529 Edwards Lifesciences shares in Q3 2025, an estimated $276K.
  • MBB Public Markets first reported a position in Edwards Lifesciences in Q4 2021 and held it in 5 quarters.
  • MBB Public Markets's Edwards Lifesciences position peaked at $4.05M in Q2 2024.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.